BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«D-Amino-Acid Oxidase

Below is an extended D-Amino-Acid Oxidase research listing. Click here to return to the D-Amino-Acid Oxidase main in depth entry.

Recent Publications on D-Amino-Acid Oxidase:

Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance.
INTRODUCTION: The genetic region coding for d-amino acid oxidase activator...
Direct Link
27th September, 2008
Division of Psychiatry Research, The Zucker Hillside Hospital, North
[Fusion expression of D-amino acid oxidase from Trignoposis variabilis with maltose binding protein and Vitreoscilla hemoglobin] 24th September, 2008
Department of Chemical Engineering, Tsinghua University, Beijing 100084,
Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia.
Ionotropic AMPA and NMDA glutamate receptors are ligand-gated ion channels...
Direct Link
23rd September, 2008
Neuroscience Discovery, Lilly Research Laboratories, Eli Lilly & Co.,
Long-term treatment with morphine increases the D-serine content in the rat brain by regulating the mRNA and protein expressions of serine racemase and D-amino acid oxidase. 20th September, 2008
Department of Clinical Pharmacology, Tokai University School of Medicine,
The stabilizing effects of immobilization in D-amino acid oxidase from Trigonopsis variabilis.
BACKGROUND: Immobilization of Trigonopsis variabilis D-amino acid oxidase...
Direct Link
19th September, 2008
Research Centre Applied Biocatalysis, Petersgasse 14, A-8010 Graz,
pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.
Human genes coding for pLG72 and d-amino acid oxidase have recently been...
Direct Link
18th September, 2008
Department of Biotechnology and Molecular Sciences, University of
[Structure and reaction mechanism of D-amino acid oxidase] 13th September, 2008
School of Health Sciences, Kumamoto University, Kuhonji 4-24-1, Kumamoto
Role of glutamate in schizophrenia: integrating excitatory avenues of research.
Schizophrenia is a debilitating lifelong disorder affecting up to 1% of...
Direct Link
2nd September, 2008
Department of Psychiatry & Behavioral Neurobiology, University of Alabama
Mutant rat strain lacking D: -amino-acid oxidase.
D: -Amino-acid oxidase (DAO) is known to be associated with schizophrenia....
Direct Link
22nd August, 2008
Center for Medical Science, International University of Health and
D-amino acid oxidase activity and expression are increased in schizophrenia.
Determination of the D-amino acid content in foods and in biological...
Direct Link
14th August, 2008
High Soluble Expression of D: -Amino Acid Oxidase in Escherichia coli Regulated by a Native Promoter.
To express high-active soluble D: -amino acid oxidase (DAAO), a...
Direct Link
13th August, 2008
Department of Chemical Engineering, Institute of Biochemical Engineering,
Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: A comparative study between enantiomers.
L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic...
Direct Link
26th July, 2008
Division of Bio-Analytical Chemistry, School of Pharmaceutical Sciences,
Transfection of the DAAO gene and subsequent induction of cytotoxic oxidative stress by D-alanine in 9L cells. 19th July, 2008
Department of Surgery, The First Affiliated Hospital, Guangzhou Medical
Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia.
D-Amino acid oxidase (DAO), a potential risk factor for schizophrenia, has...
Direct Link
11th July, 2008
The Institute for Enzyme Research, The University of Tokushima, Tokushima,
A biosensor for all D-amino acids using evolved D-amino acid oxidase.
Determination of the D-amino acid content in foods and in biological...
Direct Link
1st July, 2008
Dipartimento di Biotecnologie e Scienze Molecolari, Universita degli Studi
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional